Production (Stage)
Arcutis Biotherapeutics, Inc.
ARQT
$13.98
$0.322.34%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -50.95% | -16.15% | 45.55% | 34.90% | 21.50% |
| Total Receivables | 129.89% | 183.12% | 209.62% | 152.29% | 190.97% |
| Inventory | 25.42% | 10.60% | 0.73% | 32.52% | 54.92% |
| Prepaid Expenses | 21.51% | 21.70% | -53.06% | 24.26% | 18.19% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1,122.20% | -16.23% | 932.65% | 1.94% | -77.97% |
| Total Current Assets | -30.85% | 1.63% | 50.50% | 40.70% | 27.30% |
|
|
|||||
| Total Current Assets | -30.85% | 1.63% | 50.50% | 40.70% | 27.30% |
| Net Property, Plant & Equipment | -8.12% | -23.23% | -22.53% | -20.46% | -22.77% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 164.00% | 47.24% | 47.80% | -11.00% | -10.71% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | -0.17% | 664.10% |
| Total Assets | -28.09% | 2.20% | 49.29% | 38.69% | 26.11% |
|
|
|||||
| Total Accounts Payable | 89.14% | 18.58% | 46.63% | -53.70% | 3.88% |
| Total Accrued Expenses | 95.80% | 94.38% | 88.57% | 126.67% | 40.73% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.38% | 11.56% | 13,929.51% | 11.80% | 11.83% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 92.63% | 73.59% | 311.63% | 40.08% | 27.78% |
|
|
|||||
| Total Current Liabilities | 92.63% | 73.59% | 311.63% | 40.08% | 27.78% |
| Long-Term Debt | -46.93% | -46.88% | -47.66% | 2.02% | 2.03% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -26.44% | -24.25% | -22.35% | -20.69% | -19.22% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 17.65% | -32.86% | -- | -- | -- |
| Total Liabilities | -20.56% | -24.28% | 14.00% | 7.56% | 5.79% |
|
|
|||||
| Common Stock & APIC | 3.82% | 19.52% | 31.66% | 32.02% | 32.16% |
| Retained Earnings | -12.75% | -14.26% | -21.36% | -22.82% | -27.18% |
| Treasury Stock & Other | -5.26% | -275.00% | 389.67% | -0.68% | 67.87% |
| Total Common Equity | -36.58% | 77.68% | 235.30% | 131.56% | 60.98% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -36.58% | 77.68% | 235.30% | 131.56% | 60.98% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -36.58% | 77.68% | 235.30% | 131.56% | 60.98% |
|
|
|||||